Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Other Non Operating Income: 2013-2017

Historic Other Non Operating Income for Soleno Therapeutics (SLNO) over the last 4 years, with Dec 2017 value amounting to $5,000.

  • Soleno Therapeutics' Other Non Operating Income fell 98.78% to $5,000 in Q4 2017 from the same period last year, while for Dec 2017 it was -$752,000, marking a year-over-year decrease of 146.87%. This contributed to the annual value of -$62,000 for FY2018, which is 89.49% up from last year.
  • Soleno Therapeutics' Other Non Operating Income amounted to $5,000 in Q4 2017, which was up 66.67% from $3,000 recorded in Q3 2017.
  • Soleno Therapeutics' 5-year Other Non Operating Income high stood at $4.9 million for Q2 2015, and its period low was -$9.2 million during Q1 2015.
  • For the 3-year period, Soleno Therapeutics' Other Non Operating Income averaged around -$241,275, with its median value being $4,000 (2017).
  • The largest annual percentage gain for Soleno Therapeutics' Other Non Operating Income in the last 5 years was 431.43% (2015), contrasted with its biggest fall of 115,212.50% (2015).
  • Soleno Therapeutics' Other Non Operating Income (Quarterly) stood at -$104,965 in 2013, then slumped by 1,691.53% to -$1.9 million in 2014, then spiked by 135.21% to $662,200 in 2015, then tumbled by 37.86% to $411,497 in 2016, then plummeted by 98.78% to $5,000 in 2017.
  • Its Other Non Operating Income was $5,000 in Q4 2017, compared to $3,000 in Q3 2017 and -$88,000 in Q2 2017.